Stitching alternatives?
I'm soon going to implant a magnet myself, but I'm unsure if I want to stitch the wound. I was originally thinking of just bandaging it, or perhaps a liquid bandage, but then I thought of sugru. If people are using it to coat neodymium magnets for implanting, why not cover the tip of your finger in sugru after the magnet is in place? Some people may have allergic reactions, and it may not be asthetically pleasing, but I think it may work. Any reasons why this would be impractical?
Tagged:
Comments
Plus: it won't work. Sugru needs to long to cure, you would need something that hardens faster. Lepht mentioned spray plaster. This is great stuff, the bleeding should be close to a stop, however, 'cause otherwise it will push through... (tried that one before)
It's not really cheap, but it's used for wounds up to 50cm ...
just ask google what distributor is in your region for "Epiglu", "Histoacryl" or "Dermabond"
I think Dermabond was the most expencive one ...
but they all work quiet well, hardens fast and is very easy to apply
Cyanoacrylates for skin closure.
Eaglstein WH, Sullivan T.
Cyanoacrylates (CAs) were not widely adopted for medical use until recently because of lingering concerns regarding the initial tissue toxicities of the short-chain CAs. The medium-chain CAs, primarily butyl-cyanoacrylate, have been widely used in Europe and Canada for several decades and have gone a long way in dispelling any lingering concerns about tissue toxicity. The newer, longer chain CA, octyl-2-cyanoacrylate (2-OCA), now has been approved for multiple uses in the United States and has achieved widespread acceptance by the medical and lay communities. The current authors believe that this is probably only the beginning of the use of 2-OCA and other CAs in cutaneous medicine. This article discusses the use of CAs in their original cutaneous use as glues for the repair of lacerations and incisions and in their more recent use as dressings for the treatment of abrasions and wounds.
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15837150&query_hl=1)
J Surg Res. 2005 May 15;125(2):161-7.
Evaluation of an absorbable cyanoacrylate adhesive as a suture line sealant.
Ellman PI, Brett Reece T, Maxey TS, Tache-Leon C, Taylor JL, Spinosa DJ, Pineros-Fernandez AC, Rodeheaver GT, Kern JA.
BACKGROUND: Previous formulations of cyanoacrylate, though very effective, proved to have too high a tissue reactivity to be used internally. A novel cyanoacrylate compound with less tissue reactivity was recently developed. The objective of this study was to assess this novel cyanoacrylate compound for the use as vascular suture line sealant. MATERIALS AND METHODS: Twelve adult female sheep received a 6 mm PTFE interposition graft in each iliac artery, for a total of 24 grafts. Using oxidized cellulose (Surgicel) as a control, two formulations of a new cyanoacrylate compound (named "compound A" and "compound B") were assessed during this trial. Hemostatic efficiency was measured at the time of operation by the assessment of bleeding time and amount of blood loss. Long-term graft patency was assessed angiographically at 4, 6, and 18 months. Tissue reaction at 2 weeks, 1, 6, and 18 months was assessed grossly by vascular surgeons and microscopically by a blinded pathologist. RESULTS: Average time to hemostasis was 37.6, 50.6, and 219 s in group A, group B, and oxidized cellulose control groups, respectively (P<or=0.001 for both compounds versus control). There were no significant differences between groups with regards to graft patency. Histopathology analysis demonstrated mild to moderate tissue reaction at 2 weeks and 1 month in the cyanoacrylate groups compared with controls at 1 month (ANOVA P=0.004). Mild tissue reaction was seen at 6 months and 18 months, with no significant differences between groups (ANOVA P=0.08, 0.62, respectively). CONCLUSIONS: The novel cyanoacrylate compound examined in this study is a highly effective suture line sealant with only mild tissue reactivity and no significant effects on graft patency when studied over an 18 month period.
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15854669&query_hl=1)